All Articles

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma

Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer

Application of multi-omics in hepatocellular carcinoma: new prospects for classification and precise diagnosis and treatment

The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives

Sex differences in hepatocellular carcinoma

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Integrating artificial intelligence into multidisciplinary evaluations of HCC: opportunities and challenges

Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development

Minimally invasive surgery approaches in major liver resection for hepatocellular carcinoma

Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)

Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma

Functional cure of chronic hepatitis B virus infection: current therapeutic regimens

Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC

Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Is the Mediterranean diet a good preventive measure for NASH?